German biotech firm BioNTech on Monday said that second-quarter revenues more than doubled to 261 million euros ($302 million ...

BioNTech (BNTX) stock gains as the company surpasses Q2 2025 forecasts with 103% YoY revenue growth, thanks mainly to Pfizer ...

BioNTech stock was rising after the drugmaker reported better-than-expected results early Monday. The company’s ...

Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific ...

Summer heat, outdoor fun … and cold and flu symptoms? The three may not go together in many people’s minds: partly owing to ...

Subtle differences in molecular structure can have a major impact on the performance of mRNA-based drugs. The findings open ...

If you want a Covid-19 shot this fall, will your employer’s health insurance plan pay for it? There’s no clear answer. But ...

As the country continues to deal with the fallout of the infamous Jeffery Epstein files, The Root is taking a closer look at some of the most polarizing conspiracy theories in American history.

Berkshire Hathaway (NYSE: BRKa) stock fell 0.6% after Warren Buffett’s sprawling conglomerate posted a $3.76 billion ...

Explore Moderna, Inc.'s Q2 2025 earnings, with steep revenue declines and growth challenges. Click for my updated look at ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Diageo will release its full-year results on Tuesday following a tricky 2025 to date for the drinks producer. Diageo’s shares ...